Updated August 25 at 6:29pm
Biotechnology
73 results total, viewing 61 - 70
Nominations and applications for the newly expanded 2016 Tech10 Awards program are being accepted until Aug. 15. more
Alexion Pharmaceuticals Inc. is planning a $200 million phased expansion of its manufacturing plant here, to facilitate production of its drug, Soliris, and other products. more
After sitting out for most of the biotech acquisition frenzy of 2015, Amgen Inc. is ready to do a deal. more
Beltone New England, a national leader in hearing care, is hosting a “Hear for Children” campaign throughout the rest of September to raise funds for pediatric audiology at Hasbro Children’s Hospital. more
Southcoast Health recently announced that partial knee replacement surgeries are now being offered with the Navio Surgical System. more
Biotechnology drugmaker AbbVie Inc. filed a lawsuit seeking to block Amgen Inc. from selling a copy of the arthritis medicine Humira, its top seller. more
For all the fuss over tax inversions and the Obama administration’s efforts to prevent them, shares of companies that were able to plow their inversion deals through to the finish line and lock in all those (some would call them nefarious) benefits have to be soaring, right? Not so for Medtronic. more
A key piece of Gov. Gina M. Raimondo's strategy to help create more high-paying jobs is to develop a more robust medical technology and life sciences sector. Four years ago, a group of businesses in the med-tech sector formed an industry … more
Medtronic PLC, the world’s biggest maker of heart-rhythm devices, reported first-quarter profit that topped analysts’ estimates on strong demand for its newest products to monitor the heart and repair damaged valves. more
Biotechnology giant Amgen Inc. posted third- quarter earnings that topped analysts’ estimates, driven by higher drug sales, and raised its forecast for the year. more
« Prev | 1 2 | 3 | 4 | 5 | 6 | 7 | 8 Next »